Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |